Compounded topical pain creams have become an increasingly popular alternative to oral pain medications in recent years, yet there is a lack of scientific evidence to support their safety and effectiveness, as well as a "disconcerting" lack of regulatory oversight for these products, asserts a 13 May report from the National Academies of Sciences, Engineering and Medicines (NASEM). The report recommends stricter oversight of 503A pharmacies by state pharmacy boards and a more robust system for reporting adverse events.
The report could bolster the US Food and Drug Administration’s moves to put stricter controls in place for drugs made...
